Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic : Launches Drug Coated Balloon Coronary Catheter in Europe

07/26/2021 | 06:05am EDT


ę MT Newswires 2021
All news about MEDTRONIC PLC
09/15MEDTRONIC : BofA Global Healthcare Conference 2021
PU
09/14Medtronic to Seek Acquisitions
CI
09/14MEDTRONIC : Says US Patent Office Rejects Axonics' Challenge to Bladder Device Patents
MT
09/13MEDTRONIC : U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtronic Paten..
PR
09/13MEDTRONIC : Collaboration with Mpirik to Address Disparities in Care Associated with Sudde..
PR
09/13Medtronic Collaboration with Mpirik to Address Disparities in Care Associated with Sudd..
CI
09/10MEDTRONIC PLC : Regulation FD Disclosure (form 8-K)
AQ
09/09MEDTRONIC : 2021 Virtual Wells Fargo Healthcare Conference Presentation
PU
09/07MEDTRONIC : Executives to Speak at Upcoming Investor Conferences
AQ
09/07MEDTRONIC : Announces NAVABLATE Study Results Released in Late-Breaking Podium Presentatio..
PR
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 995 M - -
Net income 2022 5 704 M - -
Net Debt 2022 20 694 M - -
P/E ratio 2022 32,4x
Yield 2022 1,87%
Capitalization 173 B 173 B -
EV / Sales 2022 5,88x
EV / Sales 2023 5,51x
Nbr of Employees 90 000
Free-Float 99,7%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 29
Last Close Price 128,73 $
Average target price 145,92 $
Spread / Average Target 13,4%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC9.89%173 246
ABBOTT LABORATORIES14.05%221 372
BECTON, DICKINSON AND COMPANY3.62%74 460
HOYA CORPORATION30.10%62 558
SARTORIUS STEDIM BIOTECH78.64%56 275
ALIGN TECHNOLOGY, INC.32.80%56 070